4//SEC Filing
TESSLER ALLAN R 4
Accession 0001437749-19-017334
CIK 0000925741other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 6:32 AM ET
Size
14.7 KB
Accession
0001437749-19-017334
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
TESSLER ALLAN R
Director
Transactions
- Exercise/Conversion
Common Stock
2019-01-13+567→ 19,592 total - Exercise/Conversion
Common Stock
2019-07-26+3,594→ 23,186 total - Exercise/Conversion
Restricted Stock Units
2019-01-13−567→ 4,161 totalExercise: $0.00→ Common Stock (567 underlying) - Exercise/Conversion
Restricted Stock Units
2019-07-26−3,594→ 567 totalExercise: $0.00→ Common Stock (3,594 underlying)
Holdings
- 13,009(indirect: See footnote)
Common Stock
- 13,009(indirect: See footnote)
Common Stock
- 64,491(indirect: See footnote)
Common Stock
Footnotes (9)
- [F1]Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.
- [F2]Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.
- [F3]The converted RSU corresponds to a 1:1 common stock issuance.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F5]On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date.
- [F6]On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.
- [F7]These shares are held by ART/FGT Family Limited Partnership, of which the Reporting Person and his spouse are limited partners.
- [F8]These shares are held by International Financial Group, and the Reporting Person may be deemed to have beneficial ownership of such shares.
- [F9]These shares are held by Tessler Family Limited Partnership, and the Reporting Person may be deemed to have beneficial ownership of such shares.
Documents
Issuer
BioCardia, Inc.
CIK 0000925741
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0000905084
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 6:32 AM ET
- Size
- 14.7 KB